Physician

Mary Mcdaniel, MD

According to 2025 Medicare claims, Mary Mcdaniel, MD (NPI: 1184015984) practices dermatology in the Green Bay, WI market, with the plurality of this provider's patient population coming from Brown, WI. This provider's primary affiliated billing organization is FOREFRONT DERMATOLOGY, S.C. (NPI: 1588857247; TIN: 391351587) and primary practice location at 54115-1067. Mcdaniel is affiliated with the THEDACARE ACO (ACO ID: A4988), participating under the MSSP model.

Mcdaniel's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 494 traditional Medicare patients, billed 2,013 HCPCS/CPT codes, and received $108,901 in Medicare payments. The top billing code was 17110 (Destruction of skin growth, 1-14 growths). Part D data shows 969 prescription claims across 412 beneficiaries totaling $240,335 in drug costs, led by Cosentyx Unoready Pen (Secukinumab). Open Payments data shows 89 records totaling $1,463. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider has fewer than 5 years of reported Medicare Part B carrier billing data, so a reliable trend cannot be assigned. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $3,593 to $240,335. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$54K$109K2023 Medicare payment: $33,676 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $108,901 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
2020N/RN/RN/R
2021N/RN/RN/R
2022N/RN/RN/R
2023187628$33,676
20244942,013$108,901

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$175K$350K2019 Drug cost: $3,593 (USD; Tot_Drug_Cst)2020 Drug cost: $39,444 (USD; Tot_Drug_Cst)2021 Drug cost: $286,862 (USD; Tot_Drug_Cst)2022 Drug cost: $350,025 (USD; Tot_Drug_Cst)2023 Drug cost: $86,429 (USD; Tot_Drug_Cst)2024 Drug cost: $240,335 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/R17$3,593
202050115$39,444
202199376$286,862
202280240$350,025
2023156296$86,429
2024412969$240,335

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
17110Destruction of skin growth, 1-14 growths7794$70
11102Biopsy of related skin growth, first growth154182$60
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more251341$56
17000Destruction of precancer skin growth, 1 growth160200$33
17003Destruction of precancer skin growth, 2-14 growths98493$5

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Cosentyx Unoready PenSecukinumab16448$122,947
Clobetasol PropionateClobetasol Propionate842,039$3,046
Doxycycline MonohydrateDoxycycline Monohydrate933,669$2,656
KetoconazoleKetoconazole1433,892$1,752
MetronidazoleMetronidazole28830$1,751

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.89$1,463ABBVIE INC.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Mary Mcdaniel, MD?

Tedicare shows public-source Medicare data for Mary Mcdaniel, MD (NPI 1184015984), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Mary Mcdaniel, MD have ACO affiliation data?

Mary Mcdaniel, MD is shown with ACO affiliation data for THEDACARE ACO (MSSP, ACO ID A4988).

What billing organization is linked to Mary Mcdaniel, MD?

Mary Mcdaniel, MD is linked to FOREFRONT DERMATOLOGY, S.C. (billing NPI 1588857247) in the available physician profile data.

Does Mary Mcdaniel, MD have Open Payments data?

Mary Mcdaniel, MD has 89 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.